LabConnect, a Seattle, WA-based global provider of central laboratory and support services for biopharmaceutical, medical device and contract research organizations, recently secured a $4m investment.
BroadOak Capital Partners, a life sciences focused merchant bank, made the investment.
The company intends to use the funds to continue to grow operations.
Founded in 2002 and led by Eric Hayashi, president and CEO, LabConnect manages a network of global central laboratories with services including routine and esoteric laboratory testing, clinical kit building, sample tracking and management, biorepository and scientific operations support services for biopharmaceutical, medical device and contract research organizations around the world. To accommodate growth, the company recently added a new 42,000-square-foot operations center in Johnson City, Tenn. with sample management and biorepository capabilities as well as space for efficient kit-building operations.